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Abstract
Background
Stroke care and outcomes have improved significantly over the past decades. It is unclear if
patients who had a stroke in hospital (in-hospital stroke, IHS) experienced similar improve-
ments to those who were admitted with stroke (community-onset stroke, COS).
Methods
Data from the South London Stroke Register were analysed to estimate trends in processes
of care and outcomes across three cohorts (1995–2001, 2002–2008, 2009–2015). Kaplan-
Meier survival curves were calculated for each cohort. Associations between patient loca-
tion at stroke onset, processes of care, and outcomes were investigated using multiple logis-
tic regression and Cox proportional hazards models.
Results
Of 5,119 patients admitted to hospital and registered between 1995 and 2015, 552(10.8%)
had IHS. Brain imaging rates increased from 92.4%(COS) and 78.3%(IHS) in 1995–2001 to
100% for COS and IHS in 2009–2015. Rates of stroke unit admission rose but remained
lower for IHS (1995–2001: 32.2%(COS) vs. 12.4%(IHS), 2002–2008: 77.1%(COS) vs.
50.0%(IHS), 2009–2015: 86.3%(COS) vs. 65.4%(IHS)). After adjusting for patient charac-
teristics and case-mix, IHS was independently associated with lower rates of stroke unit
admission in each cohort (1995–2001: OR 0.49, 95%CI 0.29–0.82, 2002–2008: 0.29, 0.18–
0.45, 2009–2015: 0.22, 0.11–0.43). In 2009–2015, thrombolysis rates were lower for ischae-
mic IHS (17.8%(COS) vs. 13.8%(IHS)). Despite a decline, in-hospital mortality remained
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significantly higher after IHS in 2009–2015 (13.7%(COS) vs. 26.7%(IHS)). Five-year mortal-
ity rates declined for COS from 58.9%(1995–2001) to 35.2%(2009–2015) and for IHS from
80.8%(1995–2001) to 51.1%(2009–2015). In multivariable analysis, IHS was associated
with higher mortality over five years post-stroke in each cohort (1995–2001: HR 1.27, 95%
CI 1.03–1.57, 2002–2008: 1.24, 0.99–1.55, 2009–2016: 1.39, 0.95–2.04).
Conclusions
Despite significant improvements for IHS patients similar to those for COS patients, rates of
stroke unit admission and thrombolysis remain lower, and short- and long-term outcomes
poorer after IHS. Factors preventing IHS patients from entering evidence-based stroke-spe-
cific hospital pathways in a timely fashion need further investigation.
Introduction
Between 4% and 17% of all strokes occur in patients while in hospital[1, 2]. Although patients
with in-hospital stroke (IHS) avoid any pre-hospital delays and could potentially be diagnosed
and treated rapidly, they represent a particular challenge: pre-existing medical conditions can
mimic or obscure stroke symptoms and delay or prevent diagnosis[3]. Co-morbidities, e.g.
major surgery or other life-threatening acute conditions, can be contra-indications to acute
treatments such as thrombolysis[4]. IHS are generally more severe, leading, together with the
initial admission diagnosis, to longer hospital stays, higher in-hospital mortality, and worse
functional outcomes at discharge[2, 5–8].
In addition to these intrinsic challenges, a “quality gap” has been found in the care of IHS
compared to community-onset stroke (COS), with lower proportions of eligible IHS patients
receiving deficit-free, i.e. fully guideline-adherent care[2]. Delays to diagnosis and treatment,
and lower rates of brain imaging, stroke unit (SU) admission, thrombolysis for eligible IHS
patients, and secondary prevention have been widely observed, including in a previous study
from the South London Stroke Register[2–5, 8, 9].
Several studies in the last 10 years have shown that short- and long-term outcomes after
stroke generally have improved over the last few decades[10, 11], thought to be associated with
better acute care, such as thrombolysis[12] and SU care[13], as well as risk factor management
before and after stroke[10]. However, studies investigating how care and outcomes of IHS
have changed over time are lacking. It is therefore unclear if IHS patients have benefitted
equally from the recent improvements in stroke care and outcomes or whether the reported
gap between IHS and COS has worsened or improved. Additionally, no previous studies have
investigated functional outcome after IHS beyond three months or mortality beyond one year
after stroke.
The aim of this study was to compare temporal trends of acute care and short- and long-
term outcomes of IHS and COS using data from the South London Stroke Register (SLSR), an
ongoing inner-city register established in 1995.
Methods
Identification of patients
The SLSR is a population-based register, continuously ongoing since January 1995, recording
all first-in-a-lifetime strokes in a geographically defined, inner-city area of South London. At
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the 2001 UK Census, the area comprised a multi-ethnic population of 310,026 people (63%
white, 28% black, 9% other), while at the 2011 Census the population had increased to 357,308
people (56% white, 25% black, 18% other).
Multiple overlapping sources of notification were used by trained study nurses and field-
workers to maximise case ascertainment. These sources included hospital wards, neurovascu-
lar outpatient clinics, radiology requests, A&E records, and general practitioners. Capture-
recapture models estimated completeness of case ascertainment to be ~88%[14]. Stroke diag-
nosis was verified by a study clinician, using the World Health Organization clinical definition
[15].
Ethical approval
The study and its consent procedure were approved by the ethics committees of Guy’s and St
Thomas’ Hospital Trust, King’s College Hospital, Queen’s Square, and Westminster Hospital.
All patients, or their next of kin if the patient did not have capacity to consent (e.g. due to
cognitive impairment, decreased consciousness, or expressive/receptive dysphasia), gave writ-
ten informed consent to participate in the study. The fieldworker approaching the patient was
responsible for determining capacity to consent. Few patients declined to be registered (1%)
[16].
Socio-demography, pre-stroke vascular risk factors, and case mix
Sociodemographic data collected included age, sex, ethnic origin (self-defined using the 1991
Census question stratified into white, black, and other ethnic background) and socioeconomic
status (manual or non-manual occupation according to the patient’s current or most recent
employment).
Pre-stroke diagnoses of vascular risk factors were ascertained from general practitioners or
hospital records and included hypertension, hypercholesterolaemia, atrial fibrillation (AF),
transient ischaemic attack (TIA), ischaemic heart disease, diabetes mellitus, and smoking (ex-
smoker or current).
As the National Institutes of Health Stroke Scale (NIHSS)[17] was introduced into the
SLSR as a measure of stroke severity in 2004, it could not be used for the analysis of trends
since 1995. Instead, case mix was analysed using the Glasgow Coma Scale (GCS) score (dichot-
omized: <13/�13)[18], dysphagia (3-oz water swallow test), and incontinence at time of maxi-
mum impairment. Additionally, the Barthel Index (BI)[19] was recorded as a measure of
disability pre-stroke and at 7 days post-stroke (or at discharge if earlier). A BI score of<15 was
used to identify patients with moderate (BI = 10–14) or severe (BI<10) disability[20].
Stroke subtype was classified according to the Oxford Community Stroke Project classifica-
tion[21].
Processes of care
Brain imaging (stratified into no imaging, any imaging (CT and/or MRI), MRI), swallowing
assessment, SU admission (at any point during hospital stay),>50% of post-stroke hospital
stay spent in a SU, and thrombolysis rates (denominator: ischaemic strokes) were analysed as
measures of acute hospital care. Length of hospital stay was calculated as length of hospital
admission for COS or time between stroke onset and discharge for IHS.
Discharge destination was stratified into home without carer, home with carer or sheltered
accommodation, and nursing care.
At three months post-stroke, data on rehabilitation therapies (physiotherapy (PT), occupa-
tional therapy (OT), and speech and language therapy (SALT)) at any time since discharge
Trends in care and outcomes between in-hospital and community-onset stroke
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were analysed. Rates of PT or OT were based on those eligible, i.e. those with motor, sensory,
or visual deficit in the acute phase, while rates of SALT were based on those with dysphasia or
dysarthria in the acute phase. Prescribed secondary prevention therapy at three months post-
stroke included antihypertensive and statin therapy in those with a diagnosis of hypertension
and hypercholesterolaemia respectively. Rates of antiplatelet therapy were based on those with
ischaemic stroke, and anticoagulant therapy on those with ischaemic stroke and AF.
Outcome measures
Follow-up assessments were performed at three months, one year, and then annually by face-
to-face interview or postal questionnaire. Follow-up data were censored on 30 November
2017. At all follow-up points, activities of daily living were recorded using the BI. Date of death
was ascertained from hospital records, general practitioners, and the Office for National
Statistics.
Statistical methods
Patients were stratified into community-onset stroke (COS) or in-hospital stroke (IHS). Both
groups were further stratified into three consecutive seven-year cohorts according to year of
stroke (1995–2001, 2002–2008, 2009–2015).
Unadjusted differences between COS and IHS were investigated using Chi-squared test for
binary variables, the unpaired t-test for age, and the Mann-Whitney U test for length of hospi-
tal admission. These analyses were repeated for each cohort. P values for trend were calculated
for both patient groups using the Cochran-Armitage tests for trend. Multivariable logistic
regression was used to calculate adjusted estimates of the impact of patient location at stroke
(COS or IHS) on receipt of appropriate care in the acute phase, in-hospital death, and dis-
charge destination for each cohort. Adjustment variables were socio-demographic factors (age,
sex, ethnicity, and socioeconomic status), pre-stroke vascular risk factors, case mix variables
(GCS score, incontinence, dysphagia, and BI), stoke subtype, and SU admission (for discharge
destination).
Three-month and five-year outcomes were stratified into dead, moderately/severely dis-
abled (BI<15), and mildly disabled/independent (BI�15). Proportions of five-year outcomes
(Fig 1) refer to patients who have reached five years post-stroke.
Survival analyses up to five years after COS and IHS were performed stratified by cohort
using the Kaplan-Meier method (unadjusted) and Log-rank tests. For each cohort, multivari-
ate survival analysis was undertaken using cox proportional hazards models to estimate the
prognostic value of IHS on survival, adjusting for socio-demographic factors, pre-stroke vascu-
lar risk factors, case mix, stroke subtype, SU admission, and imaging.
To assess the robustness of the results to missing data, we performed sensitivity analyses
using multiple imputation of missing data based on inverse probability weights. The probabil-
ity of response was estimated with multivariable logistic regression including factors associated
with dropping out (cognitive score at previous visits, age, socioeconomic status, and ethnicity).
This approach had little effect on the estimates. The observed data analysis was therefore used
for the present study.
All tests were 2 tailed, and P values <0.05 were considered statistically significant. All statis-
tical analyses were performed using Stata 14.2 (StataCorp, Texas, USA).
Results
5,790 stroke patients were registered between January 1995 and December 2015. 604 (10.4%)
non-hospitalised patients were excluded from the analysis, as well as 67 (1.2%) patients with
Trends in care and outcomes between in-hospital and community-onset stroke
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unknown patient location at the time of stroke onset. Out of 5119 admitted stroke patients,
552 (10.8%) experienced a stroke while admitted to hospital for another cause, with the pro-
portion declining from 12.4% in 1995–2001 to 10.3% in 2002–2008, and 9.5% in 2009–2015.
50.6% of IHS patients experienced a stroke on an acute medical ward (managing various
conditions relating to cardiology, endocrinology, or gastroenterology, and respiratory or infec-
tious diseases), whereas the remainder were on surgical/neurosurgical wards (15.7%/0.9%),
ITU/HDU (13.6%), geriatric wards (9.1%), or other wards (9.4%).
Table 1 illustrates changes in baseline characteristics over time. Average age of COS and
IHS patients at index stroke fell and the significant age difference between COS and IHS seen
in the earlier cohorts (P<0.001) was not significant in 2009–2015 (P = 0.150). The proportion
of white ethnicity declined in both groups, mirroring the trend in the source population, with
a significantly larger proportion of white ethnicity in the IHS compared to the COS group con-
tinuing across all three cohorts. While the pre-stroke diagnosis of ischaemic heart disease
declined in both groups, it was significantly more common in IHS patients in each cohort
(P<0.001). IHS patients continued to have more pre-stroke disability and more clinical
impairments after stroke than COS patients, despite an improvement in impairments. There
was a significant decline of the proportion of total anterior circulation infarcts in COS and
IHS patients.
Table 2 shows rates of care interventions in the acute and early phase post-stroke stratified
by patient location and cohort. While IHS patients were less likely than COS patients to have
Fig 1. Proportion of dead, severely/moderately disabled (BI<15), or mildly/not disabled (BI�15) patients.
Abbreviations: BI Barthel Index.
https://doi.org/10.1371/journal.pone.0212396.g001
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brain imaging in 1995–2001 (COS:92.4% vs. IHS 78.3%, P<0.001), imaging frequency
increased to 100% in both groups in 2009–2015. In contrast, the frequency of swallowing
assessments declined from 94.4% (COS) and 95.3% (IHS) in 1995–2001 (P = 0.594) to 84.9%
(COS) and 72.9% (IHS) in 2009–2015 (P<0.001). SU admission rose significantly in both
groups from 32.2% and 12.4% in 1995–2001 (P<0.001) to 86.3% and 65.4% in 2009–2015
(P<0.001) for COS and IHS respectively. Similarly, the proportion of patients spending over
50% of their hospital admission on a SU increased significantly in both patient groups. Throm-
bolysis rates were 10.0% (COS) and 5.1% (IHS) in 2002–2008 (P = 0.064), compared to 17.8%
(COS) and 13.8% (IHS) in 2009–2015 (P = 0.290).
During the study period, in-hospital mortality declined in absolute terms by 20.4% (COS)
and 30.2% (IHS) respectively: following COS, in-hospital mortality was 34.1% in 1995–2001,
Table 1. Baseline characteristics of the study population by cohort.
COS IHS P for trend
1995–2001 2002–2008 2009–2015 1995–2001 2002–2008 2009–2015 COS IHS
Cohort (%) 1,512(87.7) 1,792(89.7) 1,263(90.5) 213 (12.4) 206 (10.3) 133 (9.5) 0.010 0.010
Age, mean (SD) 70.6 (14.5) 69.2 (15.5) 67.6 (16.2) 74.2 (13.3) 74.4 (12.7) 69.8 (16.4) <0.001 0.024
Sex, male (%) 746 (49.3) 920 (51.3) 666 (52.7) 85 (39.9) 104 (50.5) 76 (57.1) 0.073 0.001
Ethnicity
White (%) 1,125(75.5) 1,190(68.0) 713 (57.8) 175 (85.0) 154 (77.8) 86 (67.2) <0.001 <0.001
Black (%) 288 (19.3) 440 (25.2) 428 (34.7) 29 (14.1) 29 (14.7) 29 (22.7) <0.001 0.005
Socioeconomic status
Manual (%) 854 (69.3) 938 (64.0) 399 (52.9) 95 (66.4) 101 (64.3) 34 (48.6) <0.001 0.022
Pre-stroke risk factors
Hypertension 866 (62.1) 1,160(65.7) 796 (64.5) 133 (65.2) 144 (70.2) 89 (68.5) 0.183 0.457
Hypercholesterolaemia 59 (9.9) 393 (22.4) 461 (37.9) 7 (10.3) 58 (28.6) 56 (43.4) <0.001 <0.001
Atrial fibrillation 268 (19.0) 237 (13.4) 233 (19.1) 58 (28.9) 54 (26.5) 33 (26.4) 0.893 0.595
Ischaemic heart disease 275 (19.5) 267 (15.3) 123 (10.1) 68 (33.2) 66 (32.7) 26 (20.8) <0.001 0.028
Diabetes mellitus 245 (17.3) 339 (19.2) 288 (23.3) 33 (15.9) 58 (28.6) 42 (32.6) <0.001 <0.001
Smoking 353 (38.2) 528 (46.5) 326 (39.2) 57 (44.9) 70 (54.7) 44 (51.8) 0.594 0.258
Case mix
Pre-stroke BI <15 113 (6.3) 102 (5.5) 103 (8.3) 32 (15.8) 43 (23.1) 18 (15.8) 0.051 0.732
GCS <13 438 (29.4) 479 (27.5) 296 (24.2) 96 (47.8) 98 (51.9) 32 (29.1) 0.003 0.007
Incontinence 741 (51.7) 790 (45.7) 358 (29.7) 144 (74.2) 140 (71.8) 58 (49.6) <0.001 <0.001
Dysphagia 688 (48.7) 586 (36.7) 245 (22.9) 134 (66.3) 109 (61.9) 30 (30.9) <0.001 <0.001
NIHSS >14 � 333 (27.0) 182 (17.7) � 65 (44.2) 26 (27.1) n/a n/a
Post-stroke BI (7d) <15 735 (69.0) 872 (57.0) 423 (39.4) 122 (83.0) 130 (79.8) 54 (54.6) <0.001 <0.001
Stroke subtype
TACI 260 (18.4) 214 (12.5) 145 (13.2) 51 (28.3) 36 (19.3) 15 (14.4) <0.001 0.004
PACI 329 (23.2) 503 (29.3) 370 (33.7) 39 (21.7) 71 (38.0) 42 (40.4) <0.001 <0.001
POCI 154 (10.9) 208 (12.1) 138 (12.6) 21 (11.7) 24 (12.8) 17 (16.4) 0.178 0.281
LACI 335 (23.7) 447 (26.0) 256 (23.3) 37 (20.6) 41 (21.9) 9 (8.7) 0.938 0.029
PICH 238 (16.8) 251 (14.6) 150 (13.7) 25 (13.9) 12 (6.4) 14 (13.5) 0.026 0.589
SAH 100 (7.1) 94 (5.5) 39 (3.6) 7 (3.9) 3 (1.6) 7 (6.7) <0.001 0.372
Data are count (%, excluding those with missing values) unless otherwise indicated
�not collected during that time period
Abbreviations: BI Barthel Index, GCS Glasgow Coma Scale, NIHSS National Institutes of Health Stroke Scale, TACI total anterior circulation infarct, PACI partial
anterior circulation infarct, POCI posterior circulation infarct, LACI lacunar infarct, PICH primary intracerebral haemorrhage, SAH subarachnoid haemorrhage
https://doi.org/10.1371/journal.pone.0212396.t001
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19.7% in 2002–2008, and 13.7% in 2009–2015, while after IHS it was 56.9% in 1995–2001,
44.3% in 2002–2008, and 26.7% in 2009–2015.
Median length of hospital stays shortened significantly for COS (19 days in 1995–2001 vs 7
days in 2009–2015, P for trend<0.001), but not IHS patients (21 days in 1995–2001 vs 17 days
in 2009–2015, P for trend = 0.688). Since 1995, an increasing number of COS patients were
discharged home with carer or into sheltered accommodation and less into nursing care. Dur-
ing that period, discharge destinations for IHS patients did not change significantly.
The proportion of eligible COS and IHS patients receiving PT, OT, or SALT in the first three
months after stroke increased during the study period. IHS patients received less PT or OT than
COS patients in the earlier two cohorts, but not the latest cohort. However, most differences
were statistically non-significant. There were no significant differences between COS and IHS
in secondary prevention therapies at three months post-stroke, apart from IHS patients having
had lower rates of antiplatelet therapy at three months in the earliest cohort (P = 0.002).
Multivariable logistic regression showed that, after adjusting for socio-demography, comor-
bidities, case mix variables, and stroke subtype, IHS was independently associated with lower
rates of SU admission in each cohort (1995–2001: OR 0.49, 95%CI 0.29–0.82, 2002–2008: 0.29,
0.18–0.45, 2009–2015: 0.22, 0.11–0.43). Including only ischaemic strokes after 2003 and using
Table 2. Rates of care interventions and discharge destinations by cohort.
COS IHS P for trend
1995–2001 2002–2008 2009–2015 1995–2001 2002–2008 2009–2015 COS IHS
Imaging (%)
CT and/or MRI 1,379 (92.4) 1,755 (99.0) 1,186 (100) 162 (78.3) 194 (95.1) 121 (100) <0.001 <0.001
MRI 162 (10.9) 451 (25.6) 388 (36.9) 27 (13.1) 21 (10.6) 34 (33.7) <0.001 <0.001
Swallow assessment 1,414 (94.4) 1,595 (89.2) 1,072 (84.9) 202 (95.3) 176 (85.4) 97 (72.9) <0.001 <0.001
SU admission 483 (32.2) 1,369 (77.1) 1.090 (86.3) 26 (12.4) 102 (50.0) 87 (65.4) <0.001 <0.001
>50% of stay on SU 128 (15.2) 1,084 (68.6) 837 (85.9) 20 (11.9) 75 (38.7) 57 (58.2) <0.001 <0.001
Thrombolysis n/a 107 (10.0) 185 (17.8) n/a 7 (5.1) 15 (13.8) n/a n/a
Hospital stay, median number of days (IQR) 19 (7–51) 13 (5–39) 7 (2–21) 21 (6–54) 20 (7–43) 17 (6–39) <0.001 0.688
Discharge destination
Home without carer 195 (30.2) 336 (24.7) 247 (24.7) 21 (29.2) 22 (19.5) 24 (27.9) 0.024 0.932
With carer / sheltered 364 (56.4) 885 (64.9) 691 (69.1) 32 (44.4) 57 (50.4) 47 (54.7) <0.001 0.203
Nursing care 87 (13.5) 142 (10.4) 62 (6.2) 19 (26.4) 34 (30.1) 15 (17.4) <0.001 0.167
Care at 3 months
PT or OT after d/c� 75 (25.9) 187 (53.0) 323 (48.1) 3 (10.0) 15 (40.5) 30 (57.7) <0.001 <0.001
SALT after d/c† 59 (14.0) 126 (25.4) 130 (37.0) 3 (7.9) 10 (22.7) 7 (41.2) <0.001 0.004
Antihypertensives‡ 333 (63.7) 475 (79.2) 265 (55.7) 25 (54.4) 34 (70.8) 19 (43.2) 0.014 0.299
Antiplatelets§ 476 (75.4) 533 (76.3) 438 (74.1) 32 (56.1) 49 (73.1) 31 (68.9) 0.601 0.143
Anticoagulation�� 46 (39.0) 53 (40.5) 66 (46.5) 4 (26.7) 10 (50.0) 8 (44.4) 0.213 0.325
Statin therapy# 32 (33.0) 323 (89.5) 285 (81.9) 0 26 (86.7) 27 (90.0) <0.001 0.003
Data are count (%, excluding those with missing values) unless otherwise indicated, Abbreviations: PT physiotherapy, OT occupational therapy, d/c discharge, SALT
speech and language therapy
� of patients with any paralysis or sensory deficit in the acute phase
† of patients with dysphasia, dysarthria, or both in the acute phase
‡ of those with hypertension
§ of those with cerebral infarction
�� of those with cerebral infarction and atrial fibrillation
# of those with hypercholesterolaemia
https://doi.org/10.1371/journal.pone.0212396.t002
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the same adjustment variables as above, IHS was also linked to lower rates of thrombolysis, but
this did not reach statistical significance (OR 0.67, 0.37–1.19). Including the whole study popu-
lation, IHS was independently associated with higher rates of in-hospital mortality after adjust-
ing for the variables above (OR 1.60, 1.16–2.21), but this association was not statistically
significant in the latter two cohorts (1995–2001: OR 1.33, 0.79–2.22, 2002–2008: 1.95, 1.19–
3.19, 2009–2015: 1.63, 0.61–4.34). Similarly, IHS was significantly associated with higher rates
of discharge into nursing care overall (OR 1.77, 1.17–2.67), but after stratification this associa-
tion only remained significant for the 2002–2008 cohort (1995–2001: OR 1.56, 0.79–3.08,
2002–2008: 1.95, 1.05–3.62, 2009–2015: 1.69, 0.51–5.60).
Fig 1 presents three-month and five-year outcomes as death, severe/moderate disability,
and mild/no disability stratified by cohort. There were significant improvements of outcomes
in both groups, but mild/no disability was less common in IHS patients than COS patients in
each cohort.
Fig 2 shows unadjusted survival curves over the five years following index stroke stratified
into COS and IHS for the overall study population and for each cohort. Although survival
Fig 2. Kaplan-Meier survival estimates over 5 years following stroke.
https://doi.org/10.1371/journal.pone.0212396.g002
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rates improved in both groups (COS and IHS: log rank test between cohorts: P<0.001), sur-
vival rates were significantly lower in IHS compared to COS patients in each cohort (each
cohort: log rank test between COS and IHS: P<0.001). In all cohorts, most of the divergence
between COS and IHS patients’ survival occurred in the early phase post-stroke.
After adjusting for socio-demography, comorbidities, case mix, stroke subtype, and hospital
care processes, IHS remained associated with higher mortality rates in each cohort, while SU
admission was consistently associated with lower mortality rates (Table 3).
Discussion
This is the first study comparing temporal trends of stroke care and outcomes between IHS
and COS patients. Previous studies have compared both groups of patients regarding care and
short-term outcomes, mostly up to three months[2, 5–9]. However, they did not investigate
long-term outcomes nor, importantly, if the improvements in care and outcomes reported for
stroke patients generally were also experienced by those having IHS. This is particularly rele-
vant, as during the study period from 1995 to 2015 guidelines and service structures of stroke
care have changed significantly. In 2010, the study area within London saw the centralisation
of stroke services, during which a relatively large number of local hospitals admitting acute
stroke patients was reduced to a small number of hyper-acute stroke units[22].
Analysing the large cohort of stroke patients included in the SLSR, which is continuously
ongoing since 1995, allowed us to investigate changes in care and outcomes over the last 20
years. The main findings from this study demonstrate that care and outcomes of IHS have
improved significantly during that time. However, rates of evidence-based, acute care inter-
ventions are still lower and outcomes poorer than those of COS, even after adjusting for differ-
ences in socio-demography, comorbidities, and case mix between the two groups.
In this study, the proportion of strokes which occurred in hospital (10.8%) was significantly
higher than the 5.7% reported in the national audit of hospital-admitted stroke patients[1].
This probably reflects the high-risk patient group treated in the two main hospitals of the
Table 3. Factors influencing all-cause mortality over 5 years post-stroke, HR (95%CI)�.
1995–2001 2002–2008 2009–2015 1995–2015
IHS, vs COS 1.27 (1.03–1.57) 1.24 (0.99–1.55) 1.39 (0.95–2.04) 1.24 (1.08–1.43)
Imaging, vs none 0.26 (0.18–0.40) 0.26 (0.06–1.09) N/A 0.33 (0.23–0.47)
SU admission, vs none 0.71 (0.60–0.84) 0.56 (0.47–0.68) 0.60 (0.40–0.90) 0.65 (0.58–0.73)
Age, vs <65
65–74 1.89 (1.50–2.38) 3.15 (2.43–4.09) 3.54 (2.26–5.55) 2.51 (2.14–2.94)
�75 3.24 (2.61–4.04) 5.50 (4.30–7.03) 7.59(5.09–11.33) 4.53 (3.91–5.26)
Female, vs male 1.02 (0.88–1.19) 0.94 (0.81–1.09) 0.92 (0.72–1.18) 0.99 (0.90–1.09)
Ethnicity, vs white
Black 0.82 (0.66–1.01) 0.89 (0.72–1.09) 0.79 (0.60–1.05) 0.85 (0.75–0.96)
other 0.53 (0.35–0.80) 0.73 (0.51–1.05) 0.66 (0.38–1.14) 0.63 (0.49–0.80)
Stroke subtype, vs IS
PICH 0.90 (0.73–1.10) 1.18 (0.95–1.48) 0.71 (0.46–1.10) 0.97 (0.85–1.12)
SAH 0.92 (0.63–1.36) 0.71 (0.44–1.15) 0.24 (0.03–1.72) 0.63–1.13)
�adjusted for the variables shown, as well as socio-economic status, pre-stroke vascular risk factors, and case mix
variables, Abbreviations: IS ischaemic stroke, PICH primary intracerebral haemorrhage, SAH subarachnoid
haemorrhage
https://doi.org/10.1371/journal.pone.0212396.t003
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study area, which both serve as major tertiary centres for various specialities leading to a higher
risk of IHS[5], especially cardiothoracic surgery, interventional cardiology, and neurosurgery.
Processes of care
Measures of acute care (imaging, SU admission, and thrombolysis rates) and early-phase ther-
apies (secondary prevention, PT, OT, and SALT) show increased rates in both groups. This
reflects the implementation of evidence-based stroke care guidelines[23] across both groups of
stroke patients. Imaging rates of 100% and rates of SU admissions of well over 80% and 60%
for COS and IHS respectively indicate major improvements in clinical practice over the study
period and are also similar to current national estimates[1]. Despite these positive trends, this
study shows a continuation of the previously reported disadvantage of IHS patients[2, 9]: dedi-
cated, multi-disciplinary SU care and thrombolysis remained significantly less common after
IHS than COS in the most recent cohort.
There are valid medical reasons for not being transferred to a SU, such as serious competing
illnesses which warrant primary treatment in critical care, or post-surgical or coronary care
units. This study does not contain data on the initial admission diagnosis or hospital proce-
dures of IHS patients and therefore the causes for not being transferred to a SU could not be
investigated in detail. However, when analysing the association between IHS and rates of SU
admission, we adjusted for as many of the validated case mix variables as possible[24], includ-
ing comorbidity profiles and clinical assessments at the time of maximal impairments. Within
the limitation of this analysis, a significant, independent link between IHS and lower rates of
SU admission was confirmed in this multivariable analysis.
Avoidable, non-medical barriers of entering the standard (usually admission-) stroke care
pathway, as found in previous studies[2, 25], might continue to play an additional role, e.g.
physicians and nurses managing IHS patients being less familiar with stroke and the evidence-
based interventions required compared to staff routinely managing stroke admissions. This
can lead to delays in symptom recognition and diagnosis, a lower priority of transfers to SUs
from wards other than the emergency department, and generally less adherence to consensus
quality process measures of care[26].
In previous reports[2, 9, 27, 28], thrombolysis rates after IHS varied widely from 3.7 to 15.7%,
presumably due to the different time points of data collection, different denominators used, and
the generally low numbers involved. The thrombolysis rate for ischaemic IHS found here for the
2009–2015 cohort (13.8%) fits into the previously reported range and nearly reaches a 2006 esti-
mate, that up to 14% of IHS patients could potentially be eligible for thrombolysis[29].
However, compared to the corresponding rates for COS, IHS thrombolysis rates were in
absolute terms 4.9% and 4.0% lower in 2002–2008 and 2009–15 respectively. This dataset does
not include information on contraindications to thrombolysis, but previous reports, which
also found lower thrombolysis rates after IHS[3, 9], pointed to higher rates of clinical contrain-
dications in IHS patients, such as recent major surgery or severe medical disorders[4, 26, 27,
30]. Additionally, they found lower thrombolysis rates also caused by significant and often pre-
ventable delays: delayed symptom recognition, e.g. due to sedation or less experienced hospital
staff[3, 26], less emergency stroke specialist referrals[4, 30, 31], and longer times from stroke
onset to imaging or treatment[25, 32]. This combination of higher rates of contraindications
to thrombolysis, as well as preventable delays in symptom recognition and diagnosis are plau-
sible explanation for the lower thrombolysis rates found here.
Our cohort pre-dates the introduction of thrombectomy services in the study area, but
thrombectomy is now available and recommended for certain patients with ischaemic stroke,
including those with contraindications to thrombolysis [23]. As a significant number of IHS
Trends in care and outcomes between in-hospital and community-onset stroke
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patients have been shown to have such contraindications, thrombectomy might offer an effec-
tive, alternative treatment particularly in this patient group. The increasing availability of this
treatment option reinforces the importance of early diagnosis in IHS patients.
In contrast to the increasing rates of brain imaging, thrombolysis, and SU admission, the fre-
quency of swallowing assessments decreased in both groups. This has been reported before[33],
but differs from results of the national stroke audit SSNAP, which reports rising rates of swal-
lowing assessment, reaching 82.6%[1]. It is unclear if this is a true decline, possibly due to the
increasing number of people with milder strokes being assessed less consistently, or an artefact
due to worsening documentation[33]. In either case, it does suggest shortcomings in care.
This study showed significant improvements in the rate of early rehabilitation and second-
ary prevention therapies post-discharge after both COS and IHS, with no significant differ-
ences between the two groups. This encouraging finding suggests, that IHS patients receive
similar levels of care after the acute phase. It might reflect a growing familiarity with evidence-
based stroke care guidelines among medical staff, especially outside dedicated stroke wards or
the acute hospital setting.
Outcomes
This study found improved outcomes for both groups of patients, probably linked to the
observed decline in stroke severity and increased use of evidence-based treatment in both
groups. Nevertheless, outcomes after IHS remained significantly poorer than after COS: longer
hospital stays, higher rates of in-hospital and long-term mortality, and less favourable func-
tional outcomes in the short- and long-term, leading to higher rates of nursing home care.
Additionally, Fig 2 demonstrates that most of the difference in overall survival rates following
IHS is due to lower survival rates in the early phase post-stroke in this patient group, underlin-
ing the relevance of acute complications and timely interventions in this patient group.
The lower rates of process measures of evidence-based care following IHS discussed above,
such as SU admissions and thrombolysis, might contribute to some of the generally poorer
outcomes after IHS, as supported by the significant, independent association between dedi-
cated, multidisciplinary SU care and improved survival rates observed in this study.
Poorer outcomes after IHS might be expected even with optimal care, since this patient
group is older, with more comorbidities and probably more contraindications to stroke treat-
ment. Associations between IHS and outcomes were therefore adjusted for the case mix vari-
ables suggested by Davenport et al.[24] and the validated case mix variables that have been
shown to predict poor outcomes and are sufficient in quality and precision. These included
socio-demography, pre-stroke disability, comorbidities, stroke subtype and clinical impair-
ments in the acute phase. As IHS remained linked to poorer outcomes after adjustment, those
factors did not fully explain the differences in outcomes between COS and IHS.
From out study alone, we cannot determine the extent that lower survival was caused by
worse care, or by baseline differences in IHS and COS patients. Further confounding factors,
which are likely to play a role, but were unavailable and therefore unadjusted for, include the
initial admission diagnosis of IHS patients and markers of patient frailty, as well as factors
relating to hospital care processes, such as the timeliness, quality, and intensity of treatment.
Those latter factors have been shown to be significantly poorer for IHS patients, as reported in
previous studies[26, 32] and discussed above.
Further methodological considerations
This observational cohort study has strengths and limitations. In addition to the weaknesses
discussed above, particularly the lack of information on the initial admission diagnosis of IHS
Trends in care and outcomes between in-hospital and community-onset stroke
PLOS ONE | https://doi.org/10.1371/journal.pone.0212396 February 21, 2019 11 / 14
patients, this study had a loss to follow-up rate of around 20% after accounting for deaths[16],
which may introduce bias. However, estimates from analyses of patients with complete data
did not differ significantly from those presented. Inner-city populations with many migrant
families are relatively mobile, making long-term follow-ups challenging. Significant efforts
were made to update patient contact details via hospital or GP records, and family members.
On the other hand, this study has several strengths. As a register which is continuously
ongoing since 1995, the SLSR provides a large, multi-ethnic cohort of over 5000 admitted
stroke patients, including more than 550 IHS patients, one of the largest samples of IHS
patients analysed so far. Additionally, the dataset is very unusual for covering more than 20
years. The large sample allows stratification into multiple groups, while still providing signifi-
cant numbers and statistical power to detect differences and trends over time. Its long-term
follow-ups produce data for the analysis of long-term functional outcomes. Additionally, as
many validated process and outcome measures have been collected continuously since 1995,
during which time policies and service structures have changed significantly, their level of
implementation and effects on outcomes could be evaluated. At the same time, variables
which were not available for the earliest cohort, such as the TOAST classification of stroke[34]
and the NIHSS score[17] as a measure of stroke severity, could not be included in the whole
analysis.
Conclusions
Patients who experience a stroke while in hospital have the potential advantage of ready access
to high quality stroke care. This study demonstrates an increase in the use of evidence-based
treatments and improvement in outcomes after IHS similar to those after COS, but also a con-
tinuing inequality in the provision of evidence-based acute care between both groups. Previous
research has shown that a significant part of this inequality is due to valid clinical reasons but
also avoidable shortcomings and delays, which are possibly still playing a role. This might
imply some room for further improvements.
In order to further advance the care of IHS patients, all hospitals require algorithms and
protocols specifically tailored to IHS patients[23], with clear lines of communication and allo-
cation of responsibilities (e.g. in-hospital stroke teams). They need to be supported by staff
training programs and audits to ensure systematic implementation. Raising awareness of the
urgency of diagnosis and treatment is particularly important in high-risk clinical areas such as
cardiology, renal wards, or cardiothoracic units, but also generally across all hospital areas.
Efforts towards these objectives are being undertaken, such as specifically discussing IHS in
the 2016 National Stroke Guidelines[23] or multidisciplinary-team education on some high-
risk hospital wards. Future studies should investigate the causes for delays in symptom recog-
nition and referral, as well as persisting obstacles to SU transfer, justified or otherwise. This
will help clinicians and service leads to develop stroke services in a way that meets IHS
patients’ specific needs by identifying critical parts of the hospital pathway.
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